-

Piper Sandler Appoints Steven Schmidt as Head of Technology Investment Banking

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank and institutional securities firm, has named Steven Schmidt as head of technology investment banking, effective immediately.

“Steve’s promotion represents an important step forward as we strengthen our leadership in the technology sector. Steve is a very talented and seasoned banker who shares our long term growth strategy for tech banking at Piper Sandler. He has made a big impact on our business and we are delighted to recognize his many efforts with this important new role,” said Scott LaRue, global co-head of investment banking and capital markets at Piper Sandler.

Schmidt is currently a managing director in technology investment banking, focusing on e-commerce, integrated payments, and financial and application software. He has more than 22 years of experience working with technology companies globally. Schmidt re-joined Piper Sandler in 2015 after spending 4 years as a senior vice president at Digital River, Inc. Prior to Digital River, he spent 11 years at Piper Sandler as a senior officer in the technology investment banking group and later as head of technology equity capital markets. Schmidt has significant experience with cross-border transactions having successfully completed deals in Canada, Israel, United Kingdom, Western Europe, Romania, China, Taiwan and Australia. He graduated from Gustavus Adolphus College with a bachelor’s degree in economics.

Piper Sandler’s technology investment banking team advises clients in application software, HR technology, vertical market software, infrastructure software, IT / networking, security, storage, internet and digital media, E-commerce, financial technology, tech-enabled services, business and IT services gaming and 3D printing. The group welcomed a new managing director, Jace Kowalzyk, earlier this month. Kowalzyk specializes in IT, networking, cloud and infrastructure software sectors.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Asset management products and services are offered through separate investment advisory affiliates.

©2020. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Summary
Piper Sandler Appoints Steven Schmidt as Head of Technology Investment Banking
Release Versions

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom